Proteasome inhibition prevents experimentally-induced endothelial dysfunction - PubMed (original) (raw)
. 2009 Jun 19;84(25-26):929-34.
doi: 10.1016/j.lfs.2009.04.016. Epub 2009 May 3.
Affiliations
- PMID: 19409913
- DOI: 10.1016/j.lfs.2009.04.016
Proteasome inhibition prevents experimentally-induced endothelial dysfunction
Mario Lorenz et al. Life Sci. 2009.
Abstract
Aims: We recently demonstrated that non-toxic inhibition of the proteasome upregulates antioxidative enzymes and leads to an adaptive transcriptional pattern in endothelial cells. We therefore hypothesized that proteasome inhibition could prevent experimentally-induced endothelial dysfunction. As there are conflicting data about the effects of proteasome inhibition on endothelial function, we investigated whether proteasome inhibition could prevent experimentally-induced endothelial dysfunction.
Main methods: Endothelial dysfunction in isolated rat aortic rings was induced by incubation of rings with TNFalpha for 48 h. To study the effects of the inhibition of the proteasome, selected rings were co-treated with proteasome inhibitors. Vasorelaxation and expression of genes involved in endothelial function were evaluated.
Key findings: Incubation of rat aortic rings with TNFalpha for 48 h led to significant dose-dependent reduction of acetylcholine-induced vasorelaxation. Co-incubation with TNFalpha and the proteasome inhibitor MG132 resulted in dose-dependent improvement of endothelium-dependent vasorelaxation in comparison to rings treated with TNFalpha alone. Levels of eNOS mRNA and protein were reduced despite improved vascular function after treatment with MG132. MG132 markedly suppressed mRNA levels of NADPH oxidase subunits and increased SOD1 expression. Superoxide production was reduced in rings incubated with MG132 in comparison to controls. TNFalpha-induced upregulation of the potent vasoconstrictor endothelin was abolished by MG132.
Significance: Proteasome inhibition prevents TNFalpha-induced vascular dysfunction by reduction of superoxide production and suppression of endothelin levels. The balance between vasoconstriction and vasodilatation is shifted in favour of endothelium-dependent vasodilation.
Similar articles
- Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity.
Vera R, Sánchez M, Galisteo M, Villar IC, Jimenez R, Zarzuelo A, Pérez-Vizcaíno F, Duarte J. Vera R, et al. Clin Sci (Lond). 2007 Feb;112(3):183-91. doi: 10.1042/CS20060185. Clin Sci (Lond). 2007. PMID: 17007611 - Anti-oxidant effects of atorvastatin in dexamethasone-induced hypertension in the rat.
Mondo CK, Yang WS, Zhang N, Huang TG. Mondo CK, et al. Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1029-34. doi: 10.1111/j.1440-1681.2006.04482.x. Clin Exp Pharmacol Physiol. 2006. PMID: 17042910 - Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
Ramzy D, Rao V, Tumiati LC, Xu N, Miriuka S, Delgado D, Ross HJ. Ramzy D, et al. Circulation. 2006 Jul 4;114(1 Suppl):I214-9. doi: 10.1161/CIRCULATIONAHA.105.000471. Circulation. 2006. PMID: 16820575 - The ubiquitin-proteasome pathway and endothelial (dys)function.
Stangl K, Stangl V. Stangl K, et al. Cardiovasc Res. 2010 Jan 15;85(2):281-90. doi: 10.1093/cvr/cvp315. Epub 2009 Sep 17. Cardiovasc Res. 2010. PMID: 19767293 Review. - Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?
Balakumar P, Chakkarwar VA, Krishan P, Singh M. Balakumar P, et al. Biomed Pharmacother. 2009 Mar;63(3):171-9. doi: 10.1016/j.biopha.2008.08.008. Epub 2008 Sep 27. Biomed Pharmacother. 2009. PMID: 18823739 Review.
Cited by
- Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes.
Caramori ML, Kim Y, Moore JH, Rich SS, Mychaleckyj JC, Kikyo N, Mauer M. Caramori ML, et al. Diabetes. 2012 Mar;61(3):739-44. doi: 10.2337/db11-0617. Epub 2012 Feb 7. Diabetes. 2012. PMID: 22315306 Free PMC article. - Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.
Cui W, Bai Y, Luo P, Miao L, Cai L. Cui W, et al. Oxid Med Cell Longev. 2013;2013:306073. doi: 10.1155/2013/306073. Epub 2013 Mar 7. Oxid Med Cell Longev. 2013. PMID: 23533688 Free PMC article. Review. - Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study.
Kastritis E, Laina A, Georgiopoulos G, Gavriatopoulou M, Papanagnou ED, Eleutherakis-Papaiakovou E, Fotiou D, Kanellias N, Dialoupi I, Makris N, Manios E, Migkou M, Roussou M, Kotsopoulou M, Stellos K, Terpos E, Trougakos IP, Stamatelopoulos K, Dimopoulos MA. Kastritis E, et al. Leukemia. 2021 May;35(5):1418-1427. doi: 10.1038/s41375-021-01141-4. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589757 Clinical Trial. - Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.
Fotiou D, Roussou M, Gakiopoulou C, Psimenou E, Gavriatopoulou M, Migkou M, Kanellias N, Dialoupi I, Eleutherakis-Papaiakovou E, Giannouli S, Delavinia C, Efstathiou K, Kontogiannis S, Terpos E, Dimopoulos MA, Kastritis E. Fotiou D, et al. Blood Cancer J. 2020 Nov 3;10(11):109. doi: 10.1038/s41408-020-00381-4. Blood Cancer J. 2020. PMID: 33149167 Free PMC article. Clinical Trial. - Proteasome inhibitor treatment in alcoholic liver disease.
Bardag-Gorce F. Bardag-Gorce F. World J Gastroenterol. 2011 May 28;17(20):2558-62. doi: 10.3748/wjg.v17.i20.2558. World J Gastroenterol. 2011. PMID: 21633661 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous